CaviCide™ HP

CaviCide HP surface disinfectant offers a 1-minute universal contact time against 70 listed pathogens, utilizing a hydrogen peroxide formulation that meets all levels of the EPA’s rigorous Emerging Viral Pathogen Claim (EPA List Q)*, including enveloped viruses, small non-enveloped viruses, and large non-enveloped viruses. The High-Performance disinfection protocol of CaviCide HP ready-to-use disinfectant helps protect both patients and staff.

REQUEST A SAMPLE

Features and Benefits

Efficient Disinfection
1-Step cleaning/disinfection** and 1-minute universal contact time for all listed pathogens ensures efficient disinfection.

Broad Spectrum Efficacy
Effective disinfection against 70 pathogens including MDRO’s (Multidrug Resistant Organisms) while qualifying for the EPA's rigorous Emerging Viral Pathogen claim against all virus tiers (enveloped, small and large non-enveloped) protecting you against future pathogens as well.

Ease of Use
Pre-saturated wipes and ready-to-use liquids require no mixing or dilution simplifying the disinfection process, reducing the risk of errors, saving time, and improving compliance.

Lowest Toxicity Level
US EPA Toxicity Category IV products minimize exposure to harmful cleaning chemicals.
The use of gloves is not required.**

_*_{List Q: Disinfectants for Emerging Virap Pathogens (EVPs),}
_{www.epa.gov/pesticide-registration/disinfectants-emerging-viral-pathogens-evps-list-q}

_{**Follow Product Label for special precleaning and PPE instructions}

Kill Claims

Mycobacterium

Mycobacterium tuberculosis var: bovis (BCG)

Viruses (Non-Enveloped)

Human Norovirus
Human Rotavirus
Rhinovirus Type 37
Rhinovirus Type 1A
Human Adenovirus Type 5
Enterovirus Type D68

Viruses (Enveloped)

Herpes simplex virus Type 1 & Type 2
Avian Influenza A virus (H7N9)
Avian Influenza A virus (H5N1)
Influenza A virus (H3N2)
Influenza B virus (H1N1)
Parainfluenza virus Type 3
Hepatitis B virus (HBV)
Human Hepatitis C virus (HCV)
Human lmmunodeficiency virus Type 1 (HIV-1)
Severe Acute Respiratory Syndrome-related Coronavirus 2 (SARS-CoV-2)
Vaccinia virus
SARS-Associated Coronavirus (SARs-CoV)
Cytomegalovirus (CMV)
Influenza A virus (H1N1) Strains A/4108/2009 and A/04/09
Human Coronavirus
Respiratory Syncytial Virus (RSV)
Measles virus

Pathogenic Fungi

Trichophyton interdigitale
Candida auris
Candida albicans
Ketoconazole-resistant Candida albicans

Bacteria

Pseudomonas aeruginosa
Staphylococcus aureus
Salmonella enterica
Bordetella pertussis
Enterococcus faecium
Klebsiella aerogenes
Klebsiella pneumoniae
Escherichia coli
Escherichia coli O157:H7
Burkholderia cepacia
Stenotrophomonas maltophilia
Streptococcus pyogenes
Listeria monocytogenes
Shigella dysenteriae
Serratia marcescens
Bordetella bronchiseptica
Campylobacter jejuni
Proteus vulgaris

Multi-Drug-Resistant Bacteria (MDRO)

Penicillin-Resistant Streptococcus pneumoniae (PRSP)
Vancomycin-Resistant Enterococcus faecalis (VRE)
Methicillin-Resistant Staphylococcus aureus (MRSA)
Hospital-Acquired and Community Acquired Methicillin-Resistant
Staphylococcus aureus (HA-MRSA and CA-MRSA)
Vancomycin Intermediate Staphylococcus aureus (VISA)
Vancomycin Resistant Staphylococcus aureus (VRSA)
Linezolid-Resistant Staphylococcus aureus (LRSA)
Carbapenem-Resistant Klebsiella pneumoniae
Multidrug-Resistant Acinetobacter baumannii (MRAB) Strains
ATCC 19606 and ATCC BAA-1605
NDM-1 Enterobacter cloacae
NDM-1 Klebsiella pneumoniae
MBL Pseudomonas aeruginosa
NMD-1 Escherichia coli
ESBL Klebsiella pneumoniae
ESBL Escherichia coli
Multidrug-Resistant Klebsiella pneumoniae
Carbapenem-Resistant Escherichia coli
Carbapenem-Resistant Enterobacter cloacae
Methicillin-Resistant Staphylococcus epidermidis (MRSE)
Multi-Drug Resistant Pseudomonas aeruginosa